Asset Allocation

As of June 30, 2025.
Type % Net
Cash 0.23%
Stock 66.94%
Bond 32.88%
Convertible 0.00%
Preferred 0.00%
Other -0.06%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.65%    % Emerging Markets: 0.25%    % Unidentified Markets: 0.10%

Americas 83.34%
83.32%
Canada 59.50%
United States 23.83%
0.01%
As of June 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 14.91%
United Kingdom 3.53%
11.37%
Denmark 0.66%
Finland 0.64%
France 1.33%
Germany 2.26%
Ireland 0.64%
Netherlands 1.48%
Norway 1.32%
Sweden 0.49%
Switzerland 2.56%
0.00%
0.00%
Greater Asia 1.66%
Japan 1.06%
0.35%
Australia 0.35%
0.25%
Singapore 0.25%
0.00%
Unidentified Region 0.10%

Bond Credit Quality Exposure

AAA 24.79%
AA 18.10%
A 29.36%
BBB 15.21%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 12.55%
Short Term 0.00%
As of June 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
35.67%
Materials
6.56%
Consumer Discretionary
5.92%
Financials
22.19%
Real Estate
1.00%
Sensitive
43.20%
Communication Services
7.21%
Energy
3.73%
Industrials
16.64%
Information Technology
15.63%
Defensive
18.98%
Consumer Staples
8.25%
Health Care
8.25%
Utilities
2.48%
Not Classified
2.15%
Non Classified Equity
2.14%
Not Classified - Non Equity
0.00%
As of June 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of June 30, 2025
Type % Net
Government 31.56%
Corporate 35.06%
Securitized 0.00%
Municipal 29.42%
Other 3.95%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
11.28%
Less than 1 Year
11.28%
Intermediate
61.31%
1 to 3 Years
11.50%
3 to 5 Years
13.24%
5 to 10 Years
36.57%
Long Term
27.41%
10 to 20 Years
11.10%
20 to 30 Years
10.09%
Over 30 Years
6.23%
Other
0.00%
As of June 30, 2025
View Bond Maturity Exposure
Start Trial